Palliation of pancreatic neoplasms

Minerva Chir. 2004 Apr;59(2):113-22.

Abstract

Pancreatic adenocarcinoma accounts for 80% of pancreatic tumours. The majority are unresectable at diagnosis and only 10% of patients survive to 1 year. Therefore, selection of appropriate palliative procedures for jaundice, gastric outlet obstruction or pain is a vitally important aspect of the management of these patients. Overall survival is equivalent following surgical or non-surgical palliation of biliary obstruction. Operative biliary bypass is a more major intervention but is associated with longer relief of symptoms and fewer readmissions compared to non-operative procedures. Prognostic factors such as histopathology, presence of metastatic disease and C reactive protein levels may allow better prediction of survival, therefore aiding selection of the most appropriate palliative techniques.

Publication types

  • Review

MeSH terms

  • Abdominal Pain / etiology
  • Abdominal Pain / therapy
  • Adenocarcinoma / complications
  • Biomarkers, Tumor / blood
  • Digestive System Surgical Procedures* / methods
  • Drainage
  • Gastric Outlet Obstruction / etiology
  • Gastric Outlet Obstruction / surgery
  • Gastric Outlet Obstruction / therapy*
  • Humans
  • Jaundice, Obstructive / etiology
  • Jaundice, Obstructive / surgery
  • Jaundice, Obstructive / therapy*
  • Pain, Intractable / etiology
  • Pain, Intractable / therapy
  • Palliative Care*
  • Pancreatic Neoplasms / complications*
  • Pancreatic Neoplasms / therapy
  • Predictive Value of Tests
  • Prognosis

Substances

  • Biomarkers, Tumor